Micronutrients decrease incidence of common infections in type 2 diabetic outpatients
Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue, Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue
Abstract
A randomized, double-blind, placebo-controlled trial was carried out to investigate the effects of micronutrients supplementation on immunity and the incidence of common infections in type 2 diabetic outpatients. A total of 196 type 2 diabetic outpatients were randomized to receive tablets of micronutrients (n=97) or placebo (n=99) for 6 months. Individualized dietary energy intake and daily physical activity were recommended. Anthropometric measurements, blood biochemical variables and the incidence of common infections were measured at baseline and at 6 months. Data on diet, exercise and infection (upper respiratory tract infection, skin infection, urinary and genital tract infections, other infections) were recorded 1 month before the study and every month during the study. Blood concentrations of total protein, iron (Fe), folic acid and hemoglobin increased and unsaturated iron-binding capacity(UIBC) levels were decreased in the micronutrients supplementation group compared to the placebo group at 6 months. Moreover, at 6 months, compared to the placebo group, the blood concentrations of IgE, CD4+, CD4+/CD8+, WBC, lymphocyte counts, basophilic leukocyte increased and CD8+ count decreased in the supplementation group, and the levels of IgA, IgM, IgG and complements C3 and C4 did not differ. The incidence of upper respiratory infection, whitlow, dermapostasis, vaginitis, urinary tract infection, gingivitis and dental ulcer were lower and body temperature and duration of fever greatly improved in the supplementation than the placebo group. These data indicated that supplementation of micronutrients might increase immune function and reduce the incidence of common infections in type 2 diabetic outpatients.
Source: PubMed
Próximos ensaios clínicos
-
Kanglin Biotechnology (Hangzhou) Co., Ltd.Ainda não está recrutandoDoença de Parkinson (DP) | Advanced Primary PDChina
-
Carilion ClinicRecrutamentoHematoma Subdural Crônico | RecorrenteEstados Unidos
-
Mahidol UniversityAinda não está recrutandoCâncer de mama | Carcinoma Ductal In Situ
-
Biosensors Europe SAAinda não está recrutandoNSTEMI | Angina Instável (AI) | Angina (estável)Reino Unido
-
CooperVision International Limited (CVIL)Ainda não está recrutando
-
Shanghai Yueyang Integrated Medicine HospitalRecrutamentoSarcopenia em IdososChina
-
University of Management and Technology LahoreAinda não está recrutandoFarward Head PosturePaquistão
-
China National Center for Cardiovascular DiseasesAinda não está recrutandoBalão revestido de drogas | Ultrassom Intravascular | De Novo Large Coronary VesselChina
-
Korea University Anam HospitalAinda não está recrutandoFA - Fibrilação AtrialCoréia do Sul
-
Jijun WangRecrutamento
-
DiproBio (Shanghai) Co., Ltd.Ainda não está recrutandoSaúde mental | Estresse psicológicoChina
-
Emory UniversityAinda não está recrutandoGravidez relacionada | Hypertensive Disorder of Pregnancy (HDP)Estados Unidos